Videos

A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer
- OSPREY and CONDOR Trials - Evaluating F-18 DCFPyL PSMA Imaging for Prostate Cancer - Michael J. Morris
- The Biology of Prostate Cancer Metastasis and What PSMA Imaging Is Teaching Us: Presentation and Discussion - Kenneth J. Pienta
- Diagnostic Molecular Imaging for Prostate Cancer in the United States: A Focus on Lesion Localization and Distribution Using 18F-DCFPyL PET/CT at Biochemical Recurrence Lecture & Discussion - Andrei H. Iagaru
- Implications of PSMA PET Imaging for Prostate Cancer Presentation & Discussion - Oliver Sartor
- Applying Artificial Intelligence (AI) to PSMA-targeted PET Imaging Agent 18F-DCFPyL in Prostate Cancer: Lecture & Discussion- Matthew Rettig

Contemporary Treatment Strategies for ADT in prostate cancer
- Considerations of Bone Health in Men Treated for Prostate Cancer - Fred Saad
- Optimizing the Use of Androgen Deprivation Therapy in Men with Intermediate-Risk Prostate Cancer Presentation - Felix Feng
- The Role of ADT in Men Being Treated with Radiation Therapy - Daniel Spratt
- The HERO Study – Reviewing Major Adverse Cardiovascular Results - Bertrand Tombal
- Cardiovascular Disease and Androgen Axis - Targeted Drugs for Prostate Cancer- Javid Moslehi
- Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer - Michael Cookson - Alicia Morgans - Fred Saad & Neal Shore
ASCO GU 2021 Videos
Latest Videos
Featured Videos

PROfound Study
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.We previously reported that olaparib led to significantly longer imaging-based progression-free survival than the physician's choice of enzalutamide or abiraterone among men with metastatic castration-resistant prostate cancer who had qualifying alterations in homologous recombination repair genes and whose disease had progressed during previous treatment with a next-generation hormonal agent.
Read MoreHERO Study
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate CancerRead More

Everyday Urology: Volume 5, Issue 4
-
The Evolving Landscape of First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma
By Christopher J.D. Wallis, MD, PhD and Zachary Klaassen, MD, MSc -
Post-Operative Radiotherapy in Prostate Cancer – The State of the Data
By Christopher J.D. Wallis, MD, PhD and Zachary Klaassen, MD, MSc - Spotlight: International Bladder Cancer Network (IBCN) 2020 and Société Internationale d'Urologie (SIU) Virtual Conference 2020

Read More
The rapid spread of Coronavirus Disease 2019 (COVID-19), caused by the betacoronavirus SARS-CoV-2, throughout the world has had dramatic effects on healthcare systems with impacts far beyond the patients actually infected with COVID-19. Patients who manifest severe forms of COVID-19 requiring respiratory support typically require this for prolonged durations,
Read More